X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (133) 133
female (97) 97
male (79) 79
clinical neurology (66) 66
index medicus (64) 64
epilepsy (56) 56
adult (54) 54
genetics & heredity (41) 41
pregnancy (37) 37
child (34) 34
mutation (33) 33
adolescent (31) 31
pedigree (29) 29
epilepsy - drug therapy (28) 28
infant (28) 28
child, preschool (26) 26
middle aged (24) 24
neurology (24) 24
anticonvulsants - adverse effects (23) 23
genetics (23) 23
phenotype (23) 23
risk factors (22) 22
anticonvulsants - therapeutic use (21) 21
seizures (21) 21
biochemistry & molecular biology (18) 18
risk (18) 18
antiepileptic drugs (17) 17
genetic aspects (17) 17
medical genetics (17) 17
pregnancy complications - drug therapy (17) 17
young adult (17) 17
gene (16) 16
genotype (16) 16
neurosciences (16) 16
base sequence (15) 15
cohort studies (15) 15
genes (15) 15
genetic predisposition to disease (15) 15
infant, newborn (15) 15
mutations (15) 15
chromosome mapping (14) 14
epilepsy, generalized - genetics (14) 14
women (14) 14
carbamazepine (13) 13
molecular sequence data (13) 13
analysis (12) 12
dna mutational analysis (12) 12
genetic linkage (12) 12
linkage (12) 12
netherlands (12) 12
prospective studies (12) 12
valproic acid (12) 12
anticonvulsants (11) 11
epilepsy - genetics (11) 11
netherlands - epidemiology (11) 11
syndrome (11) 11
abnormalities, drug-induced - epidemiology (10) 10
abridged index medicus (10) 10
aged (10) 10
children (10) 10
diagnosis (10) 10
drug therapy, combination (10) 10
epilepsies, myoclonic - genetics (10) 10
genomes (10) 10
locus (10) 10
registries (10) 10
age (9) 9
dose-response relationship, drug (9) 9
family (9) 9
gene expression (9) 9
genetic predisposition to disease - genetics (9) 9
heterogeneity (9) 9
idiopathic generalized epilepsy (9) 9
juvenile myoclonic epilepsy (9) 9
myoclonic epilepsy, juvenile - genetics (9) 9
research (9) 9
animals (8) 8
carbamazepine - therapeutic use (8) 8
case-control studies (8) 8
exposure (8) 8
gene mutations (8) 8
mutation - genetics (8) 8
scn1a (8) 8
valproic acid - therapeutic use (8) 8
abnormalities, drug-induced - etiology (7) 7
age of onset (7) 7
association (7) 7
biomedicine (7) 7
epilepsy in pregnancy (7) 7
genetic counseling (7) 7
genetic markers (7) 7
genetic research (7) 7
human (7) 7
lamotrigine (7) 7
localization (7) 7
pediatrics (7) 7
polymerase chain reaction (7) 7
pregnant women (7) 7
prevalence (7) 7
proteins (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Neurology, The, ISSN 1474-4422, 2011, Volume 10, Issue 7, pp. 609 - 617
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2015, Volume 14, Issue 12, pp. 1148 - 1149
  New functional test systems measuring single-gene targets as well as multicomponent pathways and neuronal networks will be indispensable to make... 
Neurology | GILBERTS-SYNDROME | RISK | Clinical Neurology | ANTIEPILEPTIC DRUGS | CLINICAL NEUROLOGY | Anticonvulsants - therapeutic use | Epilepsy - drug therapy | Epilepsy - genetics | Humans | Precision Medicine | Drug therapy | Epilepsy | Drugs | Medicine | Side effects | Fetuses | Research | Pharmaceutical industry | Embryos
Journal Article
Nature Genetics, ISSN 1061-4036, 02/2014, Volume 46, Issue 2, pp. 188 - 193
Mitochondrial Ca2+ uptake has key roles in cell life and death. Physiological Ca2+ signaling regulates aerobic metabolism, whereas pathological Ca2+ overload... 
UNIPORTER | DISEASE | GENETICS & HEREDITY | MUSCULAR-DYSTROPHY | CA2+ UPTAKE | CELL-SURVIVAL | PROTEINS | MCU | Immunohistochemistry | Calcium Channels - metabolism | Calcium Signaling - physiology | Humans | DNA, Complementary - genetics | Molecular Sequence Data | Mitochondrial Membrane Transport Proteins - genetics | Histological Techniques | Cation Transport Proteins - metabolism | Base Sequence | Membrane Potential, Mitochondrial - genetics | Cation Transport Proteins - genetics | Quadriceps Muscle - pathology | Real-Time Polymerase Chain Reaction | Calcium-Binding Proteins - metabolism | Mitochondrial Membrane Transport Proteins - metabolism | Mitochondria - metabolism | Sequence Analysis, DNA | Exome - genetics | Phenotype | Analysis of Variance | Pedigree | Extrapyramidal Tracts - pathology | Fluorescent Antibody Technique | Polymorphism, Single Nucleotide - genetics | Learning Disorders - genetics | Movement Disorders - genetics | Muscular Diseases - genetics | Calcium Signaling - genetics | Calcium-Binding Proteins - genetics | Gene mutations | Cellular signal transduction | Muscle diseases | Genetic aspects | Research | Health aspects | Risk factors | Proteins | Medical research | Cell culture | Mitochondria | Genealogy | Biomedical research | Nuclear magnetic resonance--NMR | Mutation | Kinases | Muscular dystrophy
Journal Article
Journal Article
by Tomson, Torbjörn and Battino, Dina and Bonizzoni, Erminio and Craig, John and Lindhout, Dick and Perucca, Emilio and Sabers, Anne and Thomas, Sanjeev V and Vajda, Frank and Faravelli, Francesca and Pantaleoni, Chiara and Robert-Gnansia, Elisabeth and Cabral-Lim, Leonor and Čebular, Boštjan and De Marinis, Alejandro and Kälviäinen, Reetta and Khomeriki, Ketevan and Kiteva-Trencevska, Gordana and Kochen, Silvia and Kurthen, Martin and Luef, Gerhard and Martinez Ferri, Meritxell and Milovanović, Maja and Nakken, Karl Otto and Neufeld, Miri and Ohtani, Hideyuki and Russell, Aline and Safcák, Vladimír and Schmitz, Bettina and Specchio, Luigi Maria and Tettenborn, Barbara and van Puijenbroek, Eugene and Yu, Hsiang-Yu and Zarubova, Jana and Albretsen, Claus and Alvestad, Silje and Andersen, Noemi Becser and Antonini, Luisa and Arentsen, Jens and Aurlien, Dag and Barzinji, Ismael and Becerra Cuñat, Juan Luis and Bohorquez Morera, Natalia and Brodie, Martin J and Brodtkorb, Eylert and Broglio, Laura and Bruun Christensen, Elsebeth and Bušek, Petr and Cagnetti, Claudia and Canevini, Maria Paola and Carius, Astrid and Castro Vilanova, Maria Dolores and Cecconi, Michela and Chang, T-Y and Christensen, Jakob and De Maria, Giovanni and Dennig, Dieter and Diputado, Brenda and Ertresvåg, Janne Marit and Escartin, Toni and Flügel, Dominique and Forsom Sondal, Birgitte and Foschi, Nicoletta and Franza, Albertina and Fukushima, Katsuyuki and Gambardella, Antonio and Garamendi Ruiz, Iñigo and Gauffin, Helena and Gellert, Pia and Gjerstad, Leif and Gordon, Lisa and Haggag, Katrine and Halawa, Imad and Heikinheimo-Connell, Terttu and Hendgen, Tim and Hertz, Zarouhi and Hildenhagen, Odo and Hödl, Stephanie and Hogenesch, Ineke and Huuse Farmen, Anette and Inoue, Yushi and Juhl, Stefan and Kato, Masaaki and Kenou Van Rijckevorssel, Germaine and Kluck, E and Krijtová, Hana and Kumlien, Eva and Labate, Angelo and Lasch, Theresa and Lindsten, Hans and Listonova, Renata and Lossius, Rasmus and Lundgren, Anders and Malmgren, Kristina and Marečková, Iva and Marino, Daniela and Mattsson, Peter and McGonigal, Aileen and Miesczanleh, Katarzyna and Mizobuchi, Masahiro and ... and EURAP Study Group and EURAP Study Grp
The Lancet Neurology, ISSN 1474-4422, 06/2018, Volume 17, Issue 6, pp. 530 - 538
Evidence for the comparative teratogenic risk of antiepileptic drugs is insufficient, particularly in relation to the dosage used. Therefore, we aimed to... 
epilepsy | major clinical study | maternal age | hypospadias | longitudinal study | phenytoin | congenital heart malformation | cleft lip | pregnant woman | female | multiple malformation syndrome | anticonvulsive agent | Kerala | topiramate | pregnancy | valproic acid | article | To be checked by Faculty | carbamazepine | fetus disease | phenobarbital | conception | adult | fetus | male | kidney malformation | cohort analysis | fetus outcome | follow up | prevalence | neural tube defect | oxcarbazepine | live birth | congenital malformation | Ireland | anticonvulsant therapy | priority journal | human | polydactyly | teratogenicity | lamotrigine | cleft palate | United Kingdom | prenatal drug exposure | newborn | gastrointestinal malformation | first trimester pregnancy | pregnancy termination | prospective study | monotherapy | perinatal death | Australia | levetiracetam | FALSE DISCOVERY RATE | PREGNANCY REGISTERS | IN-UTERO | WOMEN | IRELAND EPILEPSY | VALPROATE | COMPARATIVE SAFETY | OUTCOMES | EXPOSURE | CLINICAL NEUROLOGY | UK EPILEPSY | Oxcarbazepine - therapeutic use | Abnormalities, Drug-Induced - epidemiology | Humans | Topiramate - therapeutic use | Anticonvulsants - therapeutic use | Carbamazepine - therapeutic use | Logistic Models | Male | Levetiracetam - therapeutic use | Lamotrigine - therapeutic use | Pregnancy Complications - drug therapy | Dose-Response Relationship, Drug | Pregnancy | Young Adult | Phenobarbital - therapeutic use | Phenytoin - therapeutic use | Adult | Epilepsy - drug therapy | Female | Valproic Acid - therapeutic use | Anticonvulsants | Birth defects | Genetic disorders | Comparative analysis | Topiramate | Congenital defects | Epilepsy | Dose dependency | Birth | Valproic acid | Antiepileptic agents | Primary care | Etiracetam | Carbamazepine | Studies | Oxcarbazepine | Progeny | Phenobarbital | Teratogenicity | Localization | Prenatal experience | Drug dosages | Phenytoin | Lamotrigine | Index Medicus | Clinical Medicine | Neurology | Neurologi | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Nature Genetics, ISSN 1061-4036, 02/2009, Volume 41, Issue 2, pp. 160 - 162
Journal Article